BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Opko Health
OPK
$1.04B
| $53M | ﹤0.01% |
36,022,431
+2,844,852
| +9% | +$4.76M |
|
2327
iShares 3-7 Year Treasury Bond ETF
IEI
$17.7B
| $52.9M | ﹤0.01% |
420,387
-109,257
| -21% | -$13.8M |
|
2328
Madrigal Pharmaceuticals
MDGL
$11.9B
| $52.8M | ﹤0.01% |
579,780
+1,682
| +0.3% | +$163K |
|
2329
Collegium Pharmaceutical
COLL
$897M
| $52.8M | ﹤0.01% |
2,565,927
+6,309
| +0.2% | +$105K |
|
2330
MBIA
MBI
$261M
| $52.2M | ﹤0.01% |
5,616,447
-171,238
| -3% | -$1.63M |
|
|
UCFC
2331
DELISTED
United Community Financial Corp
UCFC
| $52.1M | ﹤0.01% |
4,471,104
-289,231
| -6% | -$3.23M |
|
2332
Origin Bancorp
OBK
$1.65B
| $52.1M | ﹤0.01% |
1,375,597
-8,949
| -0.6% | -$314K |
|
2333
Metallus
MTUS
$900M
| $52.1M | ﹤0.01% |
6,622,417
+187,317
| +3% | +$1.17M |
|
|
ADVM
2334
DELISTED
Adverum Biotechnologies
ADVM
| $52.1M | ﹤0.01% |
451,843
+11,192
| +3% | +$986K |
|
2335
First Financial Corp
THFF
$963M
| $52M | ﹤0.01% |
1,137,102
-23,475
| -2% | -$1.04M |
|
|
EXPR
2336
DELISTED
Express, Inc.
EXPR
| $52M | ﹤0.01% |
533,581
+8,293
| +2% | +$652K |
|
|
SDC
2337
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $51.9M | ﹤0.01% |
5,942,127
+1,164,960
| +24% | +$11.7M |
|
2338
Nicolet Bankshares
NIC
$3.62B
| $51.9M | ﹤0.01% |
702,795
+135,613
| +24% | +$9.56M |
|
|
ACH
2339
Accendra Health
ACH
$99.6M
| $51.8M | ﹤0.01% |
10,009,553
+428,476
| +4% | +$2.75M |
|
2340
Mercer International
MERC
$34.8M
| $51.7M | ﹤0.01% |
4,201,796
+137,498
| +3% | +$1.68M |
|
|
HUYA
2341
Huya Inc
HUYA
$556M
| $51.5M | ﹤0.01% |
2,867,128
+2,854,171
| +22,028% | +$60.4M |
|
2342
BellRing Brands
BRBR
$1.33B
| $51.5M | ﹤0.01% |
+2,417,164
| New | +$47.3M |
|
2343
MacroGenics
MGNX
$261M
| $51.4M | ﹤0.01% |
4,722,537
+111,559
| +2% | +$1.1M |
|
2344
Equinor
EQNR
$96.3B
| $51.3M | ﹤0.01% |
2,575,344
+691,926
| +37% | +$13.1M |
|
|
CNST
2345
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $51.2M | ﹤0.01% |
1,087,584
+240,129
| +28% | +$6.93M |
|
|
MITT
2346
TPG Mortgage Investment Trust
MITT
$199M
| $51.2M | ﹤0.01% |
1,106,475
+26,902
| +2% | +$1.24M |
|
|
GLDD
2347
DELISTED
Great Lakes Dredge & Dock
GLDD
| $51.2M | ﹤0.01% |
4,515,670
-10,881
| -0.2% | -$116K |
|
2348
Central Garden & Pet Co
CENT
$2.74B
| $51.2M | ﹤0.01% |
2,058,111
-43,278
| -2% | -$1.03M |
|
|
EB
2349
DELISTED
Eventbrite
EB
| $51.1M | ﹤0.01% |
2,532,142
+18,841
| +0.7% | +$360K |
|
2350
Ingles Markets
IMKTA
$1.65B
| $51M | ﹤0.01% |
1,073,475
-6,113
| -0.6% | -$260K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.